Belvedere Trading LLC Bridge Bio Pharma, Inc. Put Options Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $36,800 - $49,664	1,600 New	1,600 $40,000
Q4 2023 Feb 13, 2024	SELL	$24.02 - $43.89 $228,190 - $416,955	-9,500 Reduced 89.62%	1,100 $44,000
Q3 2023 Oct 27, 2023	BUY	$16.89 - $35.01 $77,694 - $161,046	4,600 Added 76.67%	10,600 $279,000
Q2 2023 Aug 08, 2023	SELL	$13.29 - $18.01 $535,587 - $725,803	-40,300 Reduced 87.04%	6,000 $103,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $331,971 - $858,865	46,300 New	46,300 $767,000
Q2 2022 Jul 21, 2022	BUY	$5.21 - $12.14 $38,554 - $89,836	7,400 New	7,400 $71,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.21B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.